WARSAW - July 15, 2020 - Greenberg Traurig acted as legal counsel to UBS and IPOPEMA Securities – the Managers of the Ryvu Therapeutics new share offering.
Ryvu Therapeutics is a Polish clinical stage biopharmaceutical company developing novel small molecule therapies that address emerging targets in oncology. The Company is listed on the Warsaw Stock Exchange.
Ryvu Therapeutics offered 2.38 million new shares to its shareholders, the offering took the form of a public offering exempted from the obligation to publish an issue prospectus. Investors declared subscription for all newly issued shares, with the value exceeding PLN 140 million.
Ryvu Therapeutics intends to use the proceeds of the issue to fund its ongoing projects, in particular the development of a compound in new therapeutic indications in the area of solid tumors and AML/MDS as well as the development of its preclinical projects, discovery phase programs in the area of synthetic lethality and immune-oncology and financing its ongoing operations.
Greenberg Traurig advised UBS and IPOPEMA on the legal structure of the entire process and preparation and negotiation of the transaction documentation.
The Greenberg Traurig team included: Partners Paweł Piotrowski and Rafał Sieński and Senior Associate Agata Wiśniewska. Legal advice on U.S. and English law was provided by Greenberg Traurig London Office Partners – Dorothee Fischer-Appelt and James Mountain.
Greenberg Traurig LLP
Greenberg Traurig, LLP is an international, multi-practice law firm with approximately 2200 attorneys serving clients from 41 offices in the United States, Latin America, Europe, Asia, and the Middle East.
Greenberg Traurig Grzesiak sp.k. was named the 2019 and 2018 Most Innovative Law Firm of the Year Award for Poland by International Financial Law Review (IFLR) and the 2017 Law Firm of the Year in Poland by Chambers and Partners. The Warsaw office of Greenberg Traurig, LLP provides legal services to clients in Central Europe and beyond and consists of approximately 100 lawyers. Team members are regularly recognized as leaders in numerous practice areas. Chambers Global, Chambers Europe, IFLR1000 and EMEA Legal 500 consistently rank them among the top tiers the areas of Corporate/M&A, Capital Markets, Real Estate, Private Equity, Tax, Banking and Finance, Project Finance, Energy, Dispute Resolution and TMT.
For additional information, please visit www.gtlaw.com.